All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
BLI / Berkeley Lights Inc
|
|
|
|
|
|
|
|
CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
NEOG / Neogen Corporation
|
|
|
|
|
|
|
|
KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
STAA / STAAR Surgical Company
|
|
|
|
|
|
|
|
KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
ENOV / Enovis Corporation
|
|
|
|
|
|
|
|
CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
DALS / DA32 Life Science Tech Acquisition Corp - Class A
|
|
|
|
|
|
|
|
KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PARDES BIOSCIENCES INC
/ (69945Q105) |
|
|
|
|
|
|
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
/ VENTYX BIOSCIENCES INC
|
|
|
|
|
|
|
|
RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
XLO / Xilio Therapeutics, Inc.
|
|
|
|
|
|
|
|
OFIX / Orthofix Medical Inc.
|
|
|
|
|
|
|
|
NPCE / NeuroPace, Inc.
|
|
|
|
|
|
|
|
NRIX / Nurix Therapeutics, Inc.
|
|
|
|
|
|
|
|
AXGN / Axogen, Inc.
|
|
|
|
|
|
|
|
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
LUNG / Pulmonx Corporation
|
|
|
|
|
|
|
|
THTX / Theratechnologies Inc.
|
|
|
|
|
|
|
|
NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
INMD / InMode Ltd.
|
|
|
|
|
|
|
|
IOBT / IO Biotech, Inc.
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
TMDX / TransMedics Group, Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
CVS / CVS Health Corporation
|
|
|
|
|
|
|
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
KIDS / OrthoPediatrics Corp.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
CUTR / Cutera, Inc.
|
|
|
|
|
|
|
|
APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
HCA / HCA Healthcare, Inc.
|
|
|
|
|
|
|
|
PEPG / PepGen Inc.
|
|
|
|
|
|
|
|
DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
ISRG / Intuitive Surgical, Inc.
|
|
|
|
|
|
|
|
IMGO / Imago BioSciences Inc
|
|
|
|
|
|
|
|
PHVS / Pharvaris N.V.
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
IRMD / IRADIMED CORPORATION
|
|
|
|
|
|
|
|
CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
NARI / Inari Medical, Inc.
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DICE / DICE Therapeutics Inc
|
|
|
|
|
|
|
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
|
|
|
|
|
CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
NVST / Envista Holdings Corporation
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
INSP / Inspire Medical Systems, Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ORGO / Organogenesis Holdings Inc.
|
|
|
|
|
|
|
|
SRDX / Surmodics, Inc.
|
|
|
|
|
|
|
|
BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
CRL / Charles River Laboratories International, Inc.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
CELC / Celcuity Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
PCVX / Vaxcyte, Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
SKIN / The Beauty Health Company
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
LYRA / Lyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|